You are here

Alvotech

FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue

FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue

BioSpace

Flag link:

FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies

FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies

BioSpace

ARS Pharmaceuticals

Flag link:

Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

BioSpace

Flag link:

Alvotech gets new FDA review for Humira biosimilar

Alvotech gets new FDA review for Humira biosimilar

BioPharma Dive

Flag link:

Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment

Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment

Fierce Pharma

Teva Pharmaceutical

drug manufacturing

Flag link:

Alvotech to raise cash after third FDA rejection for Humira biosimilar

Alvotech to raise cash after third FDA rejection for Humira biosimilar

BioPharma Dive

Teva Pharmaceutical

Flag link:

Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva

Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva

Fierce Pharma

Teva Pharmaceutical

Flag link:

Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA

Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA

Business Insider

Teva Pharmaceutical

Flag link:

FDA rejects Teva’s high-potency biosimilar of Humira again

FDA rejects Teva’s high-potency biosimilar of Humira again

Pharmaphorum

Teva Pharmaceutical

Flag link:

FDA holds back Alvotech’s Humira biosimilar over manufacturing issues

FDA holds back Alvotech’s Humira biosimilar over manufacturing issues

BioPharma Dive

drug manufacturing

Flag link:

Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®

Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®

BioSpace

clinical trials

Flag link:

J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win

J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win

Fierce Pharma

Teva Pharmaceutical

Flag link:

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

Fierce Pharma

Flag link:

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

Fierce Pharma

Flag link:

Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year

Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year

Fierce Pharma

Flag link:

AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira

AbbVie’s last stand: How an Icelandic billionaire’s biosimilar has one final shot to dethrone Humira

Endpoints

Flag link:

Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'

Alvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'

Fierce Pharma

Flag link:

AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault

AbbVie accuses rival of stealing blockbuster ‘trade secrets’ as clock ticks down on biosimilar assault

Endpoints

Flag link:

Pages